Erasca


Erasca is a clinical-stage precision oncology company driven by a bold mission—to erase cancer. The company is on a journey to shut down one of cancer’s most commonly mutated signaling cascades, the RAS/MAPK pathway, which affects approximately 5.5 million lives each year worldwide.


View Website

Erasca

Erasca Key Stats

Life Sciences, Precision Health

Central

HQ in SD